Mutations in <i>LRRK2</i> as a Cause of Parkinson’s Disease-Reference-Cited by-同舟云学术

Mutations in LRRK2 as a Cause of Parkinson’s Disease

Published:2007-12-05 Issue:1 Volume:16 Page:99-105
ISSN:1424-862X
Container-title:Neurosignals
language:en
Short-container-title:Neurosignals

Author:

Giasson Benoit I.,Van Deerlin Vivianna M.

Publisher

S. Karger AG

Subject

Cellular and Molecular Neuroscience,Developmental Neuroscience,Neurology

Reference65 articles.

1. Simuni T, Hurtig HI: Parkinson's disease: the clinical picture; in Clark CM, Trojanowski JQ (eds): Neurodegenerative Dementias. New York, McGraw-Hill, 2000, pp 193-203.

2. Diagnostic Criteria for Parkinson Disease

3. The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method.

4. The substantia nigra of the human brain

5. Neuropathology of Parkinsonʼs Disease

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parkinson's Disease Associated with G2019S LRRK2 Mutations without Lewy Body Pathology;Movement Disorders Clinical Practice;2024-05-16

2. Recent advances in targeting leucine-rich repeat kinase 2 as a potential strategy for the treatment of Parkinson’s disease;Bioorganic Chemistry;2023-12

3. Astrocytes Differentiated from LRRK2-I1371V Parkinson’s-Disease-Induced Pluripotent Stem Cells Exhibit Similar Yield but Cell-Intrinsic Dysfunction in Glutamate Uptake and Metabolism, ATP Generation, and Nrf2-Mediated Glutathione Machinery;Cells;2023-06-08

4. Role of Astrocytes in Parkinson’s Disease Associated with Genetic Mutations and Neurotoxicants;Cells;2023-02-15

5. Multitarget inhibitors/probes that target LRRK2 and AURORA A kinases noncovalently and covalently;Chemical Communications;2023